Use of Favipiravir to Treat Lassa Virus Infection in Macaques

about

Recent advances in understanding Crimean-Congo hemorrhagic fever virus

P2860

Q58706047-F4B3D6D8-FAF5-4396-8BB7-4FB0F76186F3

P2860

Use of Favipiravir to Treat Lassa Virus Infection in Macaques

Item

http://www.wikidata.org/entity/Q58777764

description

article

@en

im September 2018 veröffentlichter wissenschaftlicher Artikel

@de

wetenschappelijk artikel

@nl

наукова стаття, опублікована у вересні 2018

@uk

name

Use of Favipiravir to Treat Lassa Virus Infection in Macaques

@en

Use of Favipiravir to Treat Lassa Virus Infection in Macaques

@nl

type

Item

label

Use of Favipiravir to Treat Lassa Virus Infection in Macaques

@en

Use of Favipiravir to Treat Lassa Virus Infection in Macaques

@nl

prefLabel

Use of Favipiravir to Treat Lassa Virus Infection in Macaques

@en

Use of Favipiravir to Treat Lassa Virus Infection in Macaques

@nl

P1476

Use of Favipiravir to Treat Lassa Virus Infection in Macaques

@en

P2093

Brian B Gowen

http://www.w3.org/2001/XMLSchema#string

Dana P Scott

http://www.w3.org/2001/XMLSchema#string

Greg Saturday

http://www.w3.org/2001/XMLSchema#string

Jamie Lovaglio

http://www.w3.org/2001/XMLSchema#string

Jonna B Westover

http://www.w3.org/2001/XMLSchema#string

Kyle Rosenke

http://www.w3.org/2001/XMLSchema#string

Patrick William Hanley

http://www.w3.org/2001/XMLSchema#string

Takashi Komeno

http://www.w3.org/2001/XMLSchema#string

Yousuke Furuta

http://www.w3.org/2001/XMLSchema#string

P2860

Pathogenesis of Lassa fever

Experimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in Guinea

Review of the literature and proposed guidelines for the use of oral ribavirin as postexposure prophylaxis for Lassa fever.

Favipiravir (T-705), a novel viral RNA polymerase inhibitor.

Lassa fever. Effective therapy with ribavirin

Pathogenesis of Lassa fever in cynomolgus macaques.

The broad-spectrum antiviral favipiravir protects guinea pigs from lethal Lassa virus infection post-disease onset.

Low-dose ribavirin potentiates the antiviral activity of favipiravir against hemorrhagic fever viruses

Lassa fever in West Africa: evidence for an expanded region of endemicity.

Efficacy of Favipiravir Alone and in Combination With Ribavirin in a Lethal, Immunocompetent Mouse Model of Lassa Fever.

P304

1696-1699

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3201/EID2409.180233

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2018-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29882740

http://www.w3.org/2001/XMLSchema#string

P921

favipiravir

Lassa virus

infectious disease

P932

6106425

http://www.w3.org/2001/XMLSchema#string

Use of Favipiravir to Treat Lassa Virus Infection in Macaques

about

P2860

P2860

Use of Favipiravir to Treat Lassa Virus Infection in Macaques

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932